S&P 500   3,357.16 (-0.68%)
DOW   29,129.06 (-0.92%)
QQQ   233.51 (-0.48%)
AAPL   316.32 (-2.66%)
FB   216.25 (+0.97%)
MSFT   186.25 (+0.49%)
GOOGL   1,512.97 (-0.38%)
AMZN   2,133.03 (-0.09%)
CGC   22.21 (+0.36%)
NVDA   289.37 (-0.14%)
BABA   218.18 (-0.66%)
MU   57.25 (-2.14%)
GE   12.77 (-0.47%)
TSLA   841.98 (+5.24%)
AMD   56.73 (+2.57%)
T   38.10 (-0.39%)
ACB   1.60 (+0.63%)
F   8.05 (-0.62%)
PRI   135.23 (-1.18%)
BAC   34.07 (-2.24%)
GILD   67.15 (-0.61%)
S&P 500   3,357.16 (-0.68%)
DOW   29,129.06 (-0.92%)
QQQ   233.51 (-0.48%)
AAPL   316.32 (-2.66%)
FB   216.25 (+0.97%)
MSFT   186.25 (+0.49%)
GOOGL   1,512.97 (-0.38%)
AMZN   2,133.03 (-0.09%)
CGC   22.21 (+0.36%)
NVDA   289.37 (-0.14%)
BABA   218.18 (-0.66%)
MU   57.25 (-2.14%)
GE   12.77 (-0.47%)
TSLA   841.98 (+5.24%)
AMD   56.73 (+2.57%)
T   38.10 (-0.39%)
ACB   1.60 (+0.63%)
F   8.05 (-0.62%)
PRI   135.23 (-1.18%)
BAC   34.07 (-2.24%)
GILD   67.15 (-0.61%)
S&P 500   3,357.16 (-0.68%)
DOW   29,129.06 (-0.92%)
QQQ   233.51 (-0.48%)
AAPL   316.32 (-2.66%)
FB   216.25 (+0.97%)
MSFT   186.25 (+0.49%)
GOOGL   1,512.97 (-0.38%)
AMZN   2,133.03 (-0.09%)
CGC   22.21 (+0.36%)
NVDA   289.37 (-0.14%)
BABA   218.18 (-0.66%)
MU   57.25 (-2.14%)
GE   12.77 (-0.47%)
TSLA   841.98 (+5.24%)
AMD   56.73 (+2.57%)
T   38.10 (-0.39%)
ACB   1.60 (+0.63%)
F   8.05 (-0.62%)
PRI   135.23 (-1.18%)
BAC   34.07 (-2.24%)
GILD   67.15 (-0.61%)
S&P 500   3,357.16 (-0.68%)
DOW   29,129.06 (-0.92%)
QQQ   233.51 (-0.48%)
AAPL   316.32 (-2.66%)
FB   216.25 (+0.97%)
MSFT   186.25 (+0.49%)
GOOGL   1,512.97 (-0.38%)
AMZN   2,133.03 (-0.09%)
CGC   22.21 (+0.36%)
NVDA   289.37 (-0.14%)
BABA   218.18 (-0.66%)
MU   57.25 (-2.14%)
GE   12.77 (-0.47%)
TSLA   841.98 (+5.24%)
AMD   56.73 (+2.57%)
T   38.10 (-0.39%)
ACB   1.60 (+0.63%)
F   8.05 (-0.62%)
PRI   135.23 (-1.18%)
BAC   34.07 (-2.24%)
GILD   67.15 (-0.61%)
Log in

OTCMKTS:TNGN - Tengion Stock Price, Forecast & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume10,000 shs
Average Volume6,051 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Tengion, Inc. is a regenerative medicine company focused on discovering, developing, manufacturing and commercializing a range of neo-organs, or products composed of living cells, with or without synthetic or natural materials, implanted or injected into the body to engraft into, regenerate, or replace a damaged tissue or organ. The Company, by using its Organ Regeneration Platform, it creates neo-organs using patient's own cells. The Company, based on its clinical and preclinical experience is leveraging its Organ Regeneration Platform to develop Neo-Kidney Augment for patients with advanced chronic kidney disease and Neo-Urinary Conduit for bladder cancer patients who are in need of a urinary diversion. The Company's product candidates are intended to delay or eliminate the need for chronic disease therapies, organ transplantation, and the administration of anti-rejection medications.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolOTCMKTS:TNGN
CUSIPN/A
Phone+1-336-7225855

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive TNGN News and Ratings via Email

Sign-up to receive the latest news and ratings for TNGN and its competitors with MarketBeat's FREE daily newsletter.


Tengion (OTCMKTS:TNGN) Frequently Asked Questions

What is Tengion's stock symbol?

Tengion trades on the OTCMKTS under the ticker symbol "TNGN."

Has Tengion been receiving favorable news coverage?

News coverage about TNGN stock has trended neutral this week, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Tengion earned a news sentiment score of 0.3 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 2.0 out of 10, indicating that recent media coverage is very unlikely to have an effect on the stock's share price in the next several days. View News Stories for Tengion.

Who are Tengion's key executives?

Tengion's management team includes the folowing people:
  • David I. Scheer, Independent Chairman of the Board (Age 63)
  • Carl-Johan Dalsgaard M.D., Independent Director (Age 56)
  • Diane K. Jorkasky M.D., Independent Director (Age 61)
  • Richard E. Kuntz M.D., Independent Director (Age 58)
  • Lorin Jeffry Randall, Independent Director

How do I buy shares of Tengion?

Shares of TNGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Tengion's official website?

The official website for Tengion is http://www.tengion.com/.

How can I contact Tengion?

Tengion's mailing address is 3929 Westpoint Blvd Ste G, WINSTON SALEM, NC 27103-6761, United States. The company can be reached via phone at +1-336-7225855.


MarketBeat Community Rating for Tengion (OTCMKTS TNGN)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  38 (Vote Outperform)
Underperform Votes:  57 (Vote Underperform)
Total Votes:  95
MarketBeat's community ratings are surveys of what our community members think about Tengion and other stocks. Vote "Outperform" if you believe TNGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TNGN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel